IRIS
RESTEGHINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 147
NA - Nord America 66
EU - Europa 21
Totale 234
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 93
US - Stati Uniti d'America 65
CN - Cina 47
IT - Italia 14
IN - India 5
DE - Germania 3
HK - Hong Kong 2
BE - Belgio 1
CA - Canada 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
Totale 234
Salva come PNG Salva come JPEG
Città #
Singapore 58
Shanghai 47
Boardman 17
Seattle 12
Naples 7
Milan 4
Santa Clara 4
Bengaluru 3
Genoa 2
Kowloon City 2
Brno 1
Brussels 1
Helsinki 1
Mumbai 1
Munich 1
Parabita 1
Paris 1
Toronto 1
Totale 164
Salva come PNG Salva come JPEG
Nome #
Treatment Options for Recurrent Anterior Skull Base Tumors 13
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting 8
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 7
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure 7
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 7
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment 7
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients 6
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) 6
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 6
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). 6
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 6
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). 6
Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient 5
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 5
Big Data in Head and Neck Cancer 5
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 5
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 5
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 5
Neoplasie testa collo 5
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol 5
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 5
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era 5
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 5
Sinonasal non-glandular cancers relapsing after multimodal treatments 5
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients 5
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 5
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 5
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) 5
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 5
Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma 5
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 5
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 4
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial 4
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak. 4
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract 4
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas 4
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 4
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies. 4
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 4
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 4
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer 4
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted? 4
Druggable molecular targets in skin adnexal malignancies 4
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration 4
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients? 4
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure 4
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience 4
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) 4
Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series 4
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936) 3
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 3
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience 3
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures 3
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy 3
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 3
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 3
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients 3
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 3
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 3
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 3
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 3
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer 3
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma 3
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? 2
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 2
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities 2
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 2
Totale 302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024256 0 0 0 0 0 0 0 16 51 40 67 82
2024/202546 26 5 3 6 6 0 0 0 0 0 0 0
Totale 302